Accueil/Actualités/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders ActualitésActualités de TIFPress Releases TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Moins d’une minute 211020_ TIF Announcement_COVID-19 Vaccine Boosters TagsCOVID-19 Pandemic COVID-19 Vaccinations Haemoglobin Disorders Thalassaemia Patients Healthcare Professionals AtRisk COVID-19 Vaccines Sickle cell Vulnerable #news TIF News Moins d’une minute Facebook X Linkedin Partager par email Imprimer
